Medicare Enrolled

Dr. Mark Vollenweider, M.D.

Critical Care Medicine · Orlando, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
1222 S ORANGE AVE, Orlando, FL 32806
3218417856
In practice since 2005 (20 years)
NPI: 1356331698 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vollenweider from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vollenweider? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vollenweider

Dr. Mark Vollenweider is a critical care medicine in Orlando, FL, with 20 years in practice. Based on federal Medicare data, Dr. Vollenweider performed 684 Medicare services across 585 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vollenweider received a total of $27,623 from 29 pharmaceutical and/or device companies across 163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vollenweider is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 40% volume in FL$ $27,623 industry payments

Medicare Practice Summary

Medicare Utilization ↗
684
Medicare services
Top 40% in FL for critical care medicine
585
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~34 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)98$49$232
Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope53$112$1,309
Irrigation and suction of lung airways to obtain cells using an endoscope51$5$762
New patient office visit, complex (60-74 min)50$143$637
Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound47$52$378
Office visit, established patient (30-39 min)47$75$341
Computer-assisted image-guided navigation of lung airways using an endoscope45$76$3,928
Biopsy of lobe of lung using an endoscope, 1 lobe42$31$1,066
Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes38$100$2,613
Aspiration of initial secretion of lung airway using an endoscope34$18$777
Office visit, established patient, complex (40-54 min)33$109$464
Office visit, established patient (10-19 min)30$25$145
Destruction of growth or narrowing of lung airway using an endoscope28$184$807
Initial hospital admission, moderate complexity27$103$411
Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes23$173$2,914
Biopsy of lung airway using an endoscope19$17$1,002
New patient office visit (45-59 min)19$96$499
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$27,623
Total received (2018-2024)
Avg $3,946/year across 7 years
Top 9% in FL for critical care medicine
29
Companies
163
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20,105 (72.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,486 (27.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$32 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,059
2023
$1,335
2022
$1,017
2021
$948
2020
$338
2019
$5,893
2018
$3,034

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Pulmonx Corporation
$16,469
Ethicon Inc.
$5,214
Auris Health, Inc.
$1,721
Intuitive Surgical, Inc.
$1,350
AstraZeneca Pharmaceuticals LP
$505
GlaxoSmithKline, LLC.
$363
INTUITIVE SURGICAL, INC.
$358
Boehringer Ingelheim Pharmaceuticals, Inc.
$322
Merck Sharp & Dohme Corporation
$301
Sunovion Pharmaceuticals Inc.
$241
GENZYME CORPORATION
$127
Janssen Biotech, Inc.
$102
Veran Medical Technologies, Inc.
$87
Electromed, Inc.
$61
Mallinckrodt LLC
$53
Mallinckrodt Enterprises LLC
$51
Regeneron Healthcare Solutions, Inc.
$46
Grifols USA, LLC
$42
Insmed, Inc.
$32
Fisher & Paykel Healthcare Inc
$26
Bayer HealthCare Pharmaceuticals Inc.
$25
PFIZER INC.
$23
Merck Sharp & Dohme LLC
$23
ADVANCED RESPIRATORY, INC
$19
Mylan Specialty L.P.
$18
Astellas Pharma US Inc
$16
SPR Therapeutics, Inc
$14
Genentech USA, Inc.
$13
Advanced Respiratory, Inc
$1
Top 3 companies account for 84.7% of total payments
Associated products mentioned in payments ›
120V · 60Hz · ACTHAR · ANORO · ANORO ELLIPTA · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BROVANA · CHANTIX · CHARTIS CATHETER · COMBIVENT RESPIMAT · CRESEMBA · DUPIXENT · Da Vinci Surgical System · FASENRA · IMFINZI · KEYTRUDA · LONHALA MAGNAIR · MONARCH · Monarch · Monarch Platform · NUCALA · OFEV · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · RYBREVANT · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · SPRINT PNS System · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SYMBICORT · Spin · TRELEGY ELLIPTA · The Vest System Model 105 Home Care · Xolair · Yupelri · ZEPHYR DELIVERY CATHETER · ZEPHYR ENDOBRONCHIAL VALVE · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (73%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 9% for critical care medicine in FL.

Equivalent to $4,039 per 100 Medicare services performed
Looking for a critical care medicine in Orlando?
Compare critical care medicines in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse critical care medicines nearby

Geographic Context

Critical Care Medicines within 10 mi
83
Per 100K population
5.8
County median income
$77,011
Nearest hospital
ORLANDO HEALTH
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Vollenweider is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 9%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Vollenweider experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Vollenweider performed 98 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vollenweider receive payments from pharmaceutical companies?
Yes. Dr. Vollenweider received a total of $27,623 from 29 companies across 163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vollenweider's costs compare to other critical care medicines in Orlando?
Dr. Vollenweider's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vollenweider) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →